Regeneron Pharmaceuticals Inc
Company Profile
Business description
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).
Contact
777 Old Saw Mill River Road
Tarrytown NY 10591-6707
USAT: +1 914 847-7000
E: manisha.narasimhan@regeneron.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
13,450
Regeneron Pharmaceuticals Inc News & Analysis
stocks
Contenders in the vaccine race
stocks
Three vaccines capable of US authorisation in 2020
markets
What a Covid-19 vaccine means for investors
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,909.00 | 71.60 | 0.91% |
| CAC 40 | 8,088.24 | 71.59 | 0.89% |
| DAX 40 | 18,161.01 | 243.73 | 1.36% |
| Dow JONES (US) | 38,239.66 | 153.86 | 0.40% |
| FTSE 100 | 8,139.83 | 60.97 | 0.75% |
| HKSE | 17,847.22 | 196.07 | 1.11% |
| NASDAQ | 15,927.90 | 316.14 | 2.03% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,916.24 | 111.15 | 0.94% |
| S&P 500 | 5,099.96 | 51.54 | 1.02% |
| S&P/ASX 200 | 7,641.60 | 65.70 | 0.87% |
| SSE Composite Index | 3,114.87 | 26.24 | 0.85% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| The Star Entertainment Group Ltd SGR | 0.42 | 0.03 | 7.69% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 0.79 | 0.04 | -4.82% |
| Northern Minerals Ltd NTU | 0.03 | 0.00 | 6.25% |
| South32 Ltd S32 | 3.50 | 0.13 | 3.86% |
| Pilbara Minerals Ltd PLS | 3.95 | 0.15 | 3.95% |
| Mesoblast Ltd MSB | 1.07 | 0.14 | 14.52% |
| Telstra Group Ltd TLS | 3.68 | 0.04 | 0.96% |
| Jupiter Mines Ltd JMS | 0.32 | 0.02 | 5.00% |
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.00% |